Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.
about
Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and AtherosclerosisAldosterone mediates its rapid effects in vascular endothelial cells through GPER activationInterfering with mineralocorticoid receptor activation: the past, present, and futureMinireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiologyImpaired flow-induced dilation of coronary arterioles of dogs fed a low-salt diet: roles of ANG II, PKC, and NAD(P)H oxidase.Aldosterone stimulates superoxide production in macula densa cellsMineralocorticoid receptor is involved in rat and human ocular chorioretinopathyHormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats.TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout miceMineralocorticoid receptors in vascular function and disease.Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications.Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.Vascular effects of aldosterone: sorting out the receptors and the ligands.Rapid aldosterone signaling and vascular reactivity: relax or don't do it.Endothelial mineralocorticoid receptor ablation does not alter blood pressure, kidney function or renal vessel contractility.
P2860
Q26781416-018E5FC9-920B-4C88-9D09-85239E0B1E13Q28579205-34F0728D-4848-4517-865F-61F7C351957AQ34019947-70F07F2F-483C-4A4D-A616-DC39B4D9AB49Q34267558-0D3A2113-5601-4B0B-B763-38EB15CEF037Q34357670-11A44692-B11E-4444-9795-01867EDC9B66Q35216795-48776346-E6A5-4D7C-9461-37CF30651220Q36068308-416EBBCC-31C8-49EF-9B1C-70C933188A47Q36370432-E344D8A4-4E67-40DC-8825-BC37FCCBD038Q36511154-82EC78E9-A19A-4E11-9149-2402A500C3ACQ37896953-7E9317B2-08DB-4BCD-BF76-A2983CD4FCC9Q38063297-B3BC16DF-6C35-406D-9E6A-BE9DFA8995E5Q38109661-699789E0-7759-46FF-BB33-22E27597167AQ38125527-7992D25A-97B2-4EE5-81A2-4C25B87FC4D9Q42948306-F15F5351-A9FD-4232-BE8F-DCD410253838Q52731232-A26CC55C-0DDD-4343-A5FD-F1509B8B707B
P2860
Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nitric oxide-mediated dilation ...... administration of aldosterone.
@ast
Nitric oxide-mediated dilation ...... administration of aldosterone.
@en
Nitric oxide-mediated dilation ...... administration of aldosterone.
@nl
type
label
Nitric oxide-mediated dilation ...... administration of aldosterone.
@ast
Nitric oxide-mediated dilation ...... administration of aldosterone.
@en
Nitric oxide-mediated dilation ...... administration of aldosterone.
@nl
prefLabel
Nitric oxide-mediated dilation ...... administration of aldosterone.
@ast
Nitric oxide-mediated dilation ...... administration of aldosterone.
@en
Nitric oxide-mediated dilation ...... administration of aldosterone.
@nl
P2093
P2860
P3181
P1476
Nitric oxide-mediated dilation ...... administration of aldosterone.
@en
P2093
Erwan Heylen
Gabor Kaley
P2860
P304
P356
10.1097/FJC.0B013E3181BFB00D
P407
P577
2009-12-01T00:00:00Z